Front Page
June 13, 2022
Webinar June 30: Emergency Department-Initiated Buprenorphine for Opioid Use Disorder
June 30, 2022 | 11:00am – 12:30pm (PT) | 1.5 CME/CE available | Register here! Please join the Northwest ATTC, the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network for our next joint webinar, June 30, 2022 (11am-12:30pm PT). The goal of the ATTC/CTN webinar series is to help…
June 6, 2022
How to Get Naloxone in WA State
Do you have naloxone (a.k.a. Narcan) in your first aid kit? This medication is given when an opioid overdose happens and can help save someone’s life. Anyone who uses opioids (even if they are prescribed by a physician) or who has friends or family who do should have naloxone on hand just in case. Additionally,…
May 23, 2022
ADAI in the News: How to Keep Loved Ones Safe from Fentanyl (NY Times)
ADAI Principal Research Scientist Caleb Banta-Green was interviewed by Melinda Wenner Moyer at the New York Times for this piece about how to talk about opioids with your family. Dr. Banta-Green talks about how widely and safely fentanyl is used in hospitals – “most people who have had a day surgery have had fentanyl” –…
May 20, 2022
Webinar June 2: Fentanyl and Opioid Overdose Prescribing for School Personnel
June 2, 2022 | 1:30-3:00pm PT Presenters: ADAI Continuing Education Specialist Alison Newman, MPH, Sean Hemmerle (WA DOH) and Robyn Smith (King County Behavioral Health & Recovery) This training, sponsored by the Washington Office of Superintendent of Public Instruction (OSPI), will provide an overview of the prevalence of fentanyl and how it affects the rates…
May 19, 2022
Webinar June 10: Questions and Answers from Patients About Psychedelics for SUDs
Where Can I Get Psilocybin for My Opioid Use Disorder? A Review of Questions and Answers from Patients About Psychedelics for SUDsJune 10, 2022 | 12:00-1:00pm PT This session is the third in ADAI’s quarterly “What’s the Latest” series addressing medications for opioid use disorder. Presented by Mark Duncan, MD, this installment will focus on…
May 13, 2022
New Research: Negative Attitudes About Medications for OUD Among Criminal Legal Staff
Stigma is a barrier to the treatment of opioid use disorder (OUD) in the criminal legal system, and how staff think about criminal involvement and addiction in general might explain their negative attitudes about medications for OUD (MOUD), such as buprenorphine or methadone, as well. This new paper, coauthored by ADAI Assistant Professor Mandy Owens,…
May 10, 2022
Transforming Our Communities: Sharing Innovations to Reduce Harms for People Who Use Drugs: June 7-8, 2022
Registration is open for our 3rd annual Transforming Our Communities Gathering, June 7-8, 2022, 8:30am -12:30pm PT. This 2-day virtual event aims to bring a wide range of participants together to understand the perspectives of people who use drugs, understand the importance of equitable access to care and services, build partnerships and connect people within…
May 9, 2022
Why ADAI is Using “Cannabis” Instead of “Marijuana”
Words matter. And that’s why we’re working to replace the term “marijuana” on ADAI websites and resources with “cannabis,” following the recent passing of Washington State’s HB 1210. This new law makes Washington State a pioneer on removing discriminatory language from cannabis-related official documents in the United States. The term “marijuana” came into popular usage in the U.S….
May 5, 2022
Virtual Panel: More Than Just Pipes: Lessons from the Field About Safer Smoking Supplies (May 16)
ADAI’s Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER) hosted an interactive virtual panel about how organizations can use distribution of safer smoking supplies to reach people who smoke opioids or stimulants. In this session, experts from the People’s Harm Reduction Alliance and Tacoma Needle Exchange/Dave Purchase Project shared their strategies and answer your…
May 4, 2022
New from ADAI: Using Alcohol & Cannabis Simultaneously More Harmful for Youth Than Use of Either Alone
Using alcohol and cannabis simultaneously – taking them at the same time to generate overlapping effects – produces greater negative consequences than use of either substance alone, according to this new scoping review published in Alcohol Research: Current Reviews. For this review, researchers from the UW Center for the Study of Health and Risk Behaviors…
Previous page Next page
